Highlights : Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine…
Synopsis: The objective of the issue is to meet the company’s financing needs for repayment of subordinated debt due, financing research and…
MINUTES OF THE 435th REGISTRATION COMMITTEE MEETING HELD ON 23.12.2021. The 435th meeting of the Registration Committee (RC) was held under the…
Summary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and…
Summary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…
Summary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and…
Summary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…
Summary : -Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that wholly owned subsidiary Mitsui Chemicals Agro, Inc.…
Summary – -The Indian Institute of Science (IISc) department of Microbiology and Cell Biology (MCB) and the Centre for Infectious Disease Research…
Synopsis -Ahead of its New Year’s Day decision deadline at the FDA, Xeris Biopharma has snagged an approval for Recorlev, a drug…